Expression of hypothalamic neuropeptides after acute TCDD treatment and distribution of Ah receptor repressor

Regulatory Peptides

Volumn 119, Issue 1-2, 2004, Pages 113-124

  Fetissov, Sergueï O ^a   Huang, Ping ^a   Zhang, Qing ^a   Mimura, Junsei ^b   Fujii Kuriyama, Yoshiaki ^b   Rannug, Agneta ^a   Hökfelt, Tomas ^a   Ceccatelli, Sandra ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Central nervous system; Feeding behavior; Halogenated aromatic compounds

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ANOREXIGENIC AGENT; APPETITE STIMULANT; AROMATIC HYDROCARBON RECEPTOR; MESSENGER RNA; NEUROPEPTIDE; OREXIN; XENOBIOTIC AGENT;

ARCUATE NUCLEUS; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; HISTOCHEMISTRY; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; REPRESSOR GENE; WEIGHT REDUCTION;

ADMINISTRATION, ORAL; AMPHETAMINES; ANIMALS; BODY WEIGHT; COCAINE; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; NEUROPEPTIDE Y; NEUROPEPTIDES; PRO-OPIOMELANOCORTIN; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ARYL HYDROCARBON; RESPONSE ELEMENTS; RNA, MESSENGER; TERATOGENS; TETRACHLORODIBENZODIOXIN; TIME FACTORS; TISSUE DISTRIBUTION; XENOBIOTICS;

EID: 1842735208     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2004.01.009     Document Type: Article

References (86)

1. Safe S., Hutzinger O. PCDDs and PCDFs: sources and environmental impact. Safe S., Hutzinger O., Hill T.A. Polychlorinated Dibenzo-p-Dioxins and -Furans (PCDDs/PCDFs). vol. 3:1990;1-20 Springer, Berlin.
2. Peterson R.E., Theobald H.M., Kimmel G.L. Developmental and reproductive toxicity of dioxins and related compounds: cross-species comparisons. Crit. Rev. Toxicol. 23:1993;283-335.
3. Pohjanvirta R., Tuomisto J. Short-term toxicity of 2,3,7,8- tetrachlorodibenzo-p-dioxin in laboratory animals: effects, mechanisms, and animal models. Pharmacol. Rev. 46:1994;483-549.
4. Seefeld M.D., Corbett S.W., Keesey R.E., Peterson R.E. Characterization of the wasting syndrome in rats treated with 2,3,7,8-tetrachlorodibenzo-p- dioxin. Toxicol. Appl. Pharmacol. 73:1984;311-322.
5. Keesey R.E., Hirvonen M.D. Body weight set-points: determination and adjustment. J. Nutr. 127:1997;1875S-1883S.
6. Schwartz M.W., Woods S.C., Porte D. Jr., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature. 404:2000;661-671.
7. Hassoun E.A., Li F., Abushaban A., Stohs S.J. Production of superoxide anion, lipid peroxidation and DNA damage in the hepatic and brain tissues of rats after subchronic exposure to mixtures of TCDD and its congeners. J. Appl. Toxicol. 21:2001;211-219.
8. Kohn M.C., Walker N.J., Kim A.H., Portier C.J. Physiological modeling of a proposed mechanism of enzyme induction by TCDD. Toxicology. 162:2001;193-208.
9. Unkila M., Pohjanvirta R., Honkakoski P., Torronen R., Tuomisto J. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induced ethoxyresorufin-O-deethylase (EROD) and aldehyde dehydrogenase (ALDH3) activities in the brain and liver. A comparison between the most TCDD-susceptible and the most TCDD-resistant rat strain. Biochem. Pharmacol. 46:1993;651-659.
10. Huang P., Rannug A., Ahlbom E., Håkansson H., Ceccatelli S. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the expression of cytochrome P450 1A1, the aryl hydrocarbon receptor, and the aryl hydrocarbon receptor nuclear translocator in rat brain and pituitary. Toxicol. Appl. Pharmacol. 169:2000;159-167.
11. Whitlock J.P. Jr. Induction of cytochrome P4501A1. Annu. Rev. Pharmacol. Toxicol. 39:1999;103-125.
12. Mimura J., Ema M., Sogawa K., Fujii-Kuriyama Y. Identification of a novel mechanism of regulation of Ah (dioxin) receptor function. Genes Dev. 13:1999;20-25.
13. Pohjanvirta R., Vartiainen T., Uusi-Rauva A., Monkkonen J., Tuomisto J. Tissue distribution, metabolism, and excretion of 14C-TCDD in a TCDD-susceptible and a TCDD-resistant rat strain. Pharmacol. Toxicol. 66:1990;93-100.
14. Cheng S.B., Kuchiiwa S., Nagatomo I., Akasaki Y., Uchida M., Tominaga M.et al. 2,3,7,8-Tetrachlorodibenzo-p-dioxin treatment induces c-Fos expression in the forebrain of the Long-Evans rat. Brain Res. 931:2002;176-180.
15. Unkila M., Pohjanvirta R., Tuomisto J. Biochemical effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds on the central nervous system. Int. J. Biochem. Cell Biol. 27:1995;443-455.
16. Tuomisto J., Pohjanvirta R., MacDonald E., Tuomisto L. Changes in rat brain monoamines, monoamine metabolites and histamine after a single administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Pharmacol. Toxicol. 67:1990;260-265.
17. Rozman K., Pfeifer B., Kerecsen L., Alper R.H. Is a serotonergic mechanism involved in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced appetite suppression in the Sprague-Dawley rat? Arch. Toxicol. 65:1991;124-128.
18. Russell D.H., Buckley A.R., Shah G.N., Sipes I.G., Blask D.E., Benson B. Hypothalamic site of action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol. Appl. Pharmacol. 94:1988;496-502.
19. Tuomisto J.T., Unkila M., Pohjanvirta R., Koulu M., Tuomisto L. Effect of a single dose of TCDD on the level of histamine in discrete nuclei in rat brain. Agents Actions. 33:1991;154-156.
20. Shridhar S., Farley A., Reid R.L., Foster W.G., Van Vugt D.A. The effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on corticotrophin-releasing hormone, arginine vasopressin, and pro-opiomelanocortin mRNA levels in the hypothalamus of the cynomolgus monkey. Toxicol. Sci. 63:2001;181-188.
21. Bestervelt L.L., Nolan C.J., Cai Y., Maimansomsuk P., Mousigian C.A., Piper W.N. Tetrachlorodibenzo-p-dioxin alters rat hypothalamic endorphin and mu opioid receptors. Neurotoxicol. Teratol. 13:1991;495-497.
22. Håkansson H., Ahlborg U.G. The effect of 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD) on the uptake, distribution and excretion of a single oral dose of [11,12-3H]retinyl acetate and on the vitamin A status in the rat. J. Nutr. 115:1985;759-771.
23. Larhammar D., Ericsson A., Persson H. Structure and expression of the rat neuropeptide Y gene. Proc. Natl. Acad. Sci. U. S. A. 84:1987;2068-2072.
24. Drouin J., Goodman H.M. Most of the coding region of rat ACTH β-LPH precursor gene lacks intervening sequences. Nature. 288:1980;610-613.
25. Douglass J., McKinzie A.A., Couceyro P. PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J. Neurosci. 15:1995;2471-2481.
26. Nahon J.L., Presse F., Bittencourt J.C., Sawchenko P.E., Vale W. The rat melanin-concentrating hormone messenger ribonucleic acid encodes multiple putative neuropeptides coexpressed in the dorsolateral hypothalamus. Endocrinology. 125:1989;2056-2065.
27. De Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E.et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. U. S. A. 95:1998;322-327.
28. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H.et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 92:1998;573-585.
29. Schalling M., Seroogy K., Hökfelt T., Chai S.Y., Hallman H., Persson H.et al. Neuropeptide tyrosine in the rat adrenal gland-immunohistochemical and in situ hybridization studies. Neuroscience. 24:1988;337-349.
30. Dagerlind Å., Friberg K., Bean A.J., Hökfelt T. Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry. Histochemistry. 98:1992;39-49.
31. Fetissov S.O., Jacoby A.S., Brumovsky P.R., Shine J., Iismaa T.P., Hökfelt T. Altered hippocampal expression of neuropeptides in seizure-prone GALR1 knockout mice. Epilepsia. 44:2003;1022-1033.
32. Swanson L.W. Brain Maps: Structure of the Rat Brain. 2nd ed. 1998;Elsevier, Amsterdam.
33. Zamboni L., De Martino C. Buffered picric acid formaldehyde: a new rapid fixative for electron microscopy. J. Cell Biol. 35:1967;148A.
34. Adams J.C. Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. J. Histochem. Cytochem. 40:1992;1457-1463.
35. Coons A.H. Fluorescent antibody methods. Danielli J.F. General Cytochemical Methods. 1958;399-422 Academic Press, New York.
36. Bittencourt J.C., Presse F., Arias C., Peto C., Vaughan J., Nahon J.L.et al. The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. J. Comp. Neurol. 319:1992;218-245.
37. Broberger C., De Lecea L., Sutcliffe J.G., Hökfelt T. Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems. J. Comp. Neurol. 402:1998;460-474.
38. Platt J.L., Michael A.F. Retardation of fading and enhancement of intensity of immunofluorescence by p-phenylenediamine. J. Histochem. Cytochem. 31:1983;840-842.
39. Denison M.S. Heterogeneity of rat hepatic Ah receptor: identification of two receptor forms which differ in their biochemical properties. J. Biochem. Toxicol. 7:1992;249-256.
40. Lusska A., Shen E., Whitlock J.P. Jr. Protein-DNA interactions at a dioxin-responsive enhancer. Analysis of six bona fide DNA-binding sites for the liganded Ah receptor. J. Biol. Chem. 268:1993;6575-6580.
41. Lai Z.W., Pineau T., Esser C. Identification of dioxin-responsive elements (DREs) in the 5' regions of putative dioxin-inducible genes. Chem. Biol. Interact. 100:1996;97-112.
42. Sawchenko P.E. Toward a new neurobiology of energy balance, appetite, and obesity: the anatomists weigh in. J. Comp. Neurol. 402:1998;435-441.
43. Saper C.B., Chou T.C., Elmquist J.K. The need to feed: homeostatic and hedonic control of eating. Neuron. 36:2002;199-211.
44. Friedman J.M., Halaas J.L. Leptin and the regulation of body weight in mammals. Nature. 395:1998;763-770.
45. Baskin D.G., Figlewicz Lattemann D., Seeley R.J., Woods S.C., Porte D. Jr., Schwartz M.W. Insulin and leptin: dual adiposity signals to the brain for the regulation of food intake and body weight. Brain Res. 848:1999;114-123.
46. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K.et al. A role for ghrelin in the central regulation of feeding. Nature. 409:2001;194-198.
47. Batterham R.L., Cowley M.A., Small C.J., Herzog H., Cohen M.A., Dakin C.L.et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature. 418:2002;650-654.
48. O'Shea R.D., Gundlach A.L. Preproneuropeptide Y messenger ribonucleic acid in the hypothalamic arcuate nucleus of the rat is increased by food deprivation or dehydration. J. Neuroendocrinol. 3:1991;11-14.
49. Stanley B.G., Leibowitz S.F. Neuropeptide Y injected in the paraventricular hypothalamus: a powerful stimulant of feeding behavior. Proc. Natl. Acad. Sci. U. S. A. 82:1985;3940-3943.
50. Broberger C., Johansen J., Johansson C., Schalling M., Hökfelt T. The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc. Natl. Acad. Sci. U. S. A. 95:1998;15043-15048.
51. Blomqvist A.G., Herzog H. Y-receptor subtypes-how many more? Trends Neurosci. 20:1997;294-298.
52. Gehlert D.R. Multiple receptors for the pancreatic polypeptide (PP-fold) family: physiological implications. Proc. Soc. Exp. Biol. Med. 218:1998;7-22.
53. Broberger C., Landry M., Wong H., Walsh J.N., Hökfelt T. Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus. Neuroendocrinology. 66:1997;393-408.
54. Fuxe K., Tinner B., Caberlotto L., Bunnemann B., Agnati L.F. NPY Y1 receptor like immunoreactivity exists in a subpopulation of beta-endorphin immunoreactive nerve cells in the arcuate nucleus: a double immunolabelling analysis in the rat. Neurosci. Lett. 225:1997;49-52.
55. Cowley M.A., Smart J.L., Rubinstein M., Cerdan M.G., Diano S., Horvath T.L.et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature. 411:2001;480-484.
56. Fan W., Boston B.A., Kesterson R.A., Hruby V.J., Cone R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature. 385:1997;165-168.
57. Vrang N., Larsen P.J., Clausen J.T., Kristensen P. Neurochemical characterization of hypothalamic cocaine-amphetamine-regulated transcript neurons. J. Neurosci. 19:1999;RC5.
58. Kristensen P., Judge M.E., Thim L., Ribel U., Christjansen K.N., Wulff B.S.et al. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature. 393:1998;72-76.
59. Lambert P.D., Couceyro P.R., McGirr K.M., DallVechia S.E., Smith Y., Kuhar M.J. CART peptides in the central control of feeding and interactions with neuropeptide Y. Synapse. 29:1998;293-298.
60. Abbott C.R., Rossi M., Wren A.M., Murphy K.G., Kennedy A.R., Stanley S.A.et al. Evidence of an orexigenic role for cocaine- and amphetamine-regulated transcript after administration into discrete hypothalamic nuclei. Endocrinology. 142:2001;3457-3463.
61. Tuomisto J.T., Pohjanvirta R., Unkila M., Tuomisto J. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced anorexia and wasting syndrome in rats: aggravation after ventromedial hypothalamic lesion. Eur. J. Pharmacol. 293:1995;309-317.
62. Bagnol D., Lu X.Y., Kaelin C.B., Day H.E., Ollmann M., Gantz I.et al. Anatomy of an endogenous antagonist: relationship between Agouti-related protein and proopiomelanocortin in brain. J. Neurosci. 19:1999;RC26:1-RC26:7.
63. Elias C.F., Saper C.B., Maratos-Flier E., Tritos N.A., Lee C., Kelly J.et al. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J. Comp. Neurol. 402:1998;442-459.
64. Vaughan J.M., Fischer W.H., Hoeger C., Rivier J., Vale W. Characterization of melanin-concentrating hormone from rat hypothalamus. Endocrinology. 125:1989;1660-1665.
65. Qu D., Ludwig D.S., Gammeltoft S., Piper M., Pelleymounter M.A., Cullen M.J.et al. A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature. 380:1996;243-247.
66. Rossi M., Choi S.J., O'Shea D., Miyoshi T., Ghatei M.A., Bloom S.R. Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight. Endocrinology. 138:1997;351-355.
67. Presse F., Sorokovsky I., Max J.P., Nicolaidis S., Nahon J.L. Melanin-concentrating hormone is a potent anorectic peptide regulated by food-deprivation and glucopenia in the rat. Neuroscience. 71:1996;735-745.
68. Bittencourt J.C., Elias C.F. Melanin-concentrating hormone and neuropeptide EI projections from the lateral hypothalamic area and zona incerta to the medial septal nucleus and spinal cord: a study using multiple neuronal tracers. Brain Res. 805:1998;1-19.
69. Sergeyev V., Broberger C., Hökfelt T. Effect of LPS administration on the expression of POMC, NPY, galanin, CART and MCH mRNAs in the rat hypothalamus. Mol. Brain Res. 90:2001;93-100.
70. Zamir N., Skofitsch G., Bannon M.J., Jacobowitz D.M. Melanin- concentrating hormone: unique peptide neuronal system in the rat brain and pituitary gland. Proc. Natl. Acad. Sci. U. S. A. 83:1986;1528-1531.
71. Cai X.J., Liu X.H., Evans M., Clapham J.C., Wilson S., Arch J.R.et al. Orexins and feeding: special occasions or everyday occurrence? Regul. Pept. 104:2002;1-9.
72. Griffond B., Risold P.Y., Jacquemard C., Colard C., Fellmann D. Insulin-induced hypoglycemia increases preprohypocretin (orexin) mRNA in the rat lateral hypothalamic area. Neurosci. Lett. 262:1999;77-80.
73. Mondal M.S., Nakazato M., Date Y., Murakami N., Yanagisawa M., Matsukura S. Widespread distribution of orexin in rat brain and its regulation upon fasting. Biochem. Biophys. Res. Commun. 256:1999;495-499.
74. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C.et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell. 98:1999;437-451.
75. Lin L., Faraco J., Li R., Kadotani H., Rogers W., Lin X.et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell. 98:1999;365-376.
76. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G.et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 18:1998;9996-10015.
77. Elias C.F., Lee C., Kelly J., Aschkenasi C., Ahima R.S., Couceyro P.R.et al. Leptin activates hypothalamic CART neurons projecting to the spinal cord. Neuron. 21:1998;1375-1385.
78. Bestervelt L.L., Pitt J.A., Piper W.N. Evidence for Ah receptor mediation of increased ACTH concentrations in primary cultures of rat anterior pituitary cells exposed to TCDD. Toxicol. Sci. 46:1998;294-299.
79. Huang P., Ceccatelli S., Håkansson H., Grandison L., Rannug A. Constitutive and TCDD-induced expression of Ah receptor-responsive genes in the pituitary. Neurotoxicology. 23:2002;783-793.
80. Miller C.A. III Expression of the human aryl hydrocarbon receptor complex in yeast. Activation of transcription by indole compounds. J. Biol. Chem. 272:1997;32824-32829.
81. Heath-Pagliuso S., Rogers W.J., Tullis K., Seidel S.D., Cenijn P.H., Brouwer A.et al. Activation of the Ah receptor by tryptophan and tryptophan metabolites. Biochemistry. 37:1998;11508-11515.
82. Rannug A., Rannug U., Rosenkranz H.S., Winqvist L., Westerholm R., Agurell E.et al. Certain photooxidized derivatives of tryptophan bind with very high affinity to the Ah receptor and are likely to be endogenous signal substances. J. Biol. Chem. 262:1987;15422-15427.
83. Bjeldanes L.F., Kim J.Y., Grose K.R., Bartholomew J.C., Bradfield C.A. Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8- tetrachlorodibenzo-p-dioxin. Proc. Natl. Acad. Sci. U. S. A. 88:1991;9543-9547.
84. Gillner M., Bergman J., Cambillau C., Alexandersson M., Fernstrom B., Gustafsson J.Å. Interactions of indolo[3,2-b]carbazoles and related polycyclic aromatic hydrocarbons with specific binding sites for 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver. Mol. Pharmacol. 44:1993;336-345.
85. Rannug U., Rannug A., Sjöberg U., Li H., Westerholm R., Bergman J. Structure elucidation of two tryptophan-derived, high affinity Ah receptor ligands. Chem. Biol. 2:1995;841-845.
86. Wei Y.D., Rannug U., Rannug A. UV-induced CYP1A1 gene expression in human cells is mediated by tryptophan. Chem. Biol. Interact. 118:1999;127-140.